Document Detail


Societal costs of obstructive sleep apnoea syndrome.
MedLine Citation:
PMID:  20927153     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To estimate the societal costs of obstructive sleep apnoea syndrome (OSAS) in New Zealand and develop a simulation tool to evaluate treatment options.
METHOD: Treatment profiles, availability, uptake, and costs were based on services in the Wellington Region, and were used to develop a decision analytic model with micro costing of each potential outcome. Sensitivity analyses were conducted with 10,000 Monte Carlo simulations randomly varying each model parameter between high and low estimates.
RESULTS: Total annual societal costs of OSAS for New Zealanders aged 30-60 years were estimated at $40 million (range $33-$90 million) or $419 per case, with accidents being the major contributor. This included 58% direct medical, 13% direct non-medical, 25% indirect, and 3% intangible costs. The estimated incremental net cost of treating OSAS was $389 per case treated (range $338-$427). The estimated incremental net direct medical cost per quality of life year (QALY) gained was $94 (range $56-$310).
CONCLUSION: The estimated incremental direct medical cost per QALY gained by OSAS treatment is well below the average QALY cost ($6865) for drugs selected by PHARMAC to receive government subsidy for use in the healthcare system. Thus, the analysis strongly supports the cost effectiveness of OSAS treatment.
Authors:
Philippa Gander; Guy Scott; Kara Mihaere; Helen Scott
Related Documents :
10243993 - Escalating malpractice costs: what's behind them...what preventive procedures can be ta...
19680833 - Economic burden of unjustified medications at hospital discharge.
12390553 - Ethics of practicing medical procedures on newly dead and nearly dead patients.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-27
Journal Detail:
Title:  The New Zealand medical journal     Volume:  123     ISSN:  1175-8716     ISO Abbreviation:  N. Z. Med. J.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-10-07     Completed Date:  2010-10-29     Revised Date:  2011-04-06    
Medline Journal Info:
Nlm Unique ID:  0401067     Medline TA:  N Z Med J     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  13-23     Citation Subset:  IM    
Affiliation:
Sleep/Wake Research Centre, Research School of Public Health, Massey University, Private Box 756 Wellington, New Zealand. swrc@massey.ac.nz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Accidents, Occupational / economics,  statistics & numerical data
Accidents, Traffic / economics,  statistics & numerical data
Adult
Cardiovascular Diseases / economics,  epidemiology
Cost of Illness
Cost-Benefit Analysis
Decision Support Techniques
Diabetes Mellitus / economics,  epidemiology
Health Care Costs
Humans
Middle Aged
Monte Carlo Method
New Zealand / epidemiology
Quality-Adjusted Life Years
Risk Assessment
Sleep Apnea, Obstructive / economics*,  epidemiology
Comments/Corrections
Comment In:
N Z Med J. 2010 Aug 27;123(1321):6-8   [PMID:  20927151 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Obstructive sleep apnoea syndrome.
Next Document:  Exploring knowledge and attitudes of taxi drivers with regard to obstructive sleep apnoea syndrome.